Quick Answer
Lyra Therapeutics, Inc. reported Total Revenue of $398.0 thousand for fiscal year 2025.
Lyra Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $398.0K | -74.1% |
| 2024 | $1.53M | -1.5% |
| 2023 | $1.56M | +14.3% |
| 2022 | $1.36M | +378.2% |
| 2021 | $285.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.0K | -87.2% | -86.3% |
| June 30, 2025 | $183.0K | -69.4% | +0.0% |
| March 31, 2025 | $183.0K | -65.6% | -6.2% |
| September 30, 2024 | $195.0K | -64.2% | -67.4% |
| June 30, 2024 | $598.0K | +30.6% | +12.4% |
| March 31, 2024 | $532.0K | +29.8% | -2.2% |
| September 30, 2023 | $544.0K | +51.5% | +18.8% |
| June 30, 2023 | $458.0K | -12.8% | +11.7% |
- Lyra Therapeutics, Inc. showed a decrease of -74.1% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2025 period, Lyra Therapeutics, Inc.’s total revenue has grown by 39.6% (from $285.0 thousand to $398.0 thousand).
- The most recent figure is from Lyra Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: